Cytokines and systemic sclerosis
- 30 September 1994
- journal article
- Published by Elsevier in Clinics in Dermatology
- Vol. 12 (3) , 407-417
- https://doi.org/10.1016/0738-081x(94)90293-3
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Cell Surface Expression of Lysosome-Associated Membrane Proteins (LAMPs) in Scleroderma: Relationship of lamp2 to Disease Duration, Anti-Sc170 Antibodies, Serum Interleukin-8, and Soluble Interleukin-2 Receptor LevelsClinical Immunology and Immunopathology, 1993
- Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblastsClinical Immunology and Immunopathology, 1992
- Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: Possible role for IL-6Clinical Immunology and Immunopathology, 1992
- Interleukin-6 and its relation to inflammation and diseaseClinical Immunology and Immunopathology, 1992
- Soluble and cellular markers of immune activation in patients with systemic sclerosisClinical Immunology and Immunopathology, 1990
- Persistent effect of TGF-β1 on extracellular matrix gene expression in human dermal fibroblastsBiochemical and Biophysical Research Communications, 1990
- Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferationClinical Immunology and Immunopathology, 1988
- Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)Biochemical and Biophysical Research Communications, 1988
- Exaggerated Spontaneous Release of Platelet-Derived Growth Factor by Alveolar Macrophages from Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1987
- Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-βBiochemical and Biophysical Research Communications, 1986